CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-16 | Patel Sandip I Director | Purchase · Warrants to purchase American Depositary Shares ("ADRs") | +247,462 | 247,462 | ||
| 2025-12-16 | Patel Sandip I Director | Purchase · Pre-Funded Warrants to purchase ADRs | +247,462 | $0.40 | $100K | 247,462 |
| 2025-12-16 | Patel Sandip I Director | Purchase · Warrants to purchase ADRs | +154,664 | 154,664 | ||
| 2025-12-16 | Patel Sandip I Director | Purchase · Pre-Funded Warrants to purchase ADRs | +154,664 | $0.40 | $62K | 154,664 |
| 2025-12-16 | Huh Hoyoung Director | Purchase · Warrants to purchase American Depositary Shares ("ADRs") | +618,658 | 618,658 | ||
| 2025-12-16 | Huh Hoyoung Director | Purchase · Pre-Funded Warrants to purchase ADRs | +618,658 | $0.40 | $250K | 618,658 |
| 2025-12-16 | Huh Hoyoung Director | Purchase · Warrants to purchase ADRs | +3,093,293 | 3,093,293 | ||
| 2025-12-16 | Huh Hoyoung Director | Purchase · Pre-Funded Warrants to purchase ADRs | +3,093,293 | $0.40 | $1.2M | 3,093,293 |
| 2025-12-16 | Farag Kameel D. Interim CFO | Purchase · Warrants to purchase American Depositary Shares ("ADRs") | +24,745 | 24,745 | ||
| 2025-12-16 | Farag Kameel D. Interim CFO | Purchase · Pre-Funded Warrants to purchase ADRs | +24,745 | $0.40 | $10K | 24,745 |
| 2025-12-16 | Patel Samir Rashmikant Director | Purchase · Warrants to purchase American Depositary Shares ("ADRs") | +618,658 | 618,658 | ||
| 2025-12-16 | Patel Samir Rashmikant Director | Purchase · Pre-Funded Warrants to purchase ADRs | +618,658 | $0.40 | $250K | 618,658 |
| 2025-12-16 | Patel Samir Rashmikant Director | Purchase · Warrants to purchase ADRs | +231,997 | 231,997 | ||
| 2025-12-16 | Patel Samir Rashmikant Director | Purchase · Pre-Funded Warrants to purchase ADRs | +231,997 | $0.40 | $94K | 231,997 |
| 2025-12-16 | Gaslightwala Abizer CEO | Purchase · Warrants to purchase American Depositary Shares ("ADRs") | +309,328 | 309,328 | ||
| 2025-12-16 | Gaslightwala Abizer CEO | Purchase · Pre-Funded Warrants to purchase ADRs | +309,328 | $0.40 | $125K | 309,328 |
| 2025-12-16 | Gaslightwala Abizer CEO | Purchase · Warrants to purchase ADRs | +773,323 | 773,323 | ||
| 2025-12-16 | Gaslightwala Abizer CEO | Purchase · Pre-Funded Warrants to purchase ADRs | +773,323 | $0.40 | $312K | 773,323 |
| 2025-12-16 | Bazemore Robert B Director | Purchase · Warrants to purchase American Depositary Shares ("ADRs") | +123,731 | 123,731 | ||
| 2025-12-16 | Bazemore Robert B Director | Purchase · Pre-Funded Warrants to purchase ADRs | +123,731 | $0.40 | $50K | 123,731 |
Page 4 of 11 · 216 trades